ssVERDICT: Self‐supervised VERDICT‐MRI for enhanced prostate tumor characterization
Magnetic Resonance in Medicine · 2024
DOI: 10.1002/mrm.30186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2024. Verfasst von Snigdha Sen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Image Computing, Department of Computer Science, University College London, London, UK. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Neural Networks, Computer. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, University College London Hospitals, Prostate Cancer UK.
Abstract (Originalsprache)
Purpose
Demonstrating and assessing self‐supervised machine‐learning fitting of the VERDICT (vascular, extracellular and restricted diffusion for cytometry in tumors) model for prostate cancer.
Methods
We derive a self‐supervised neural network for fitting VERDICT (ssVERDICT) that estimates parameter maps without training data. We compare the performance of ssVERDICT to two established baseline methods for fitting diffusion MRI models: conventional nonlinear least squares and supervised deep learning. We do this quantitatively on simulated data by comparing the Pearson's correlation coefficient, mean‐squared error, bias, and variance with respect to the simulated ground truth. We also calculate in vivo parameter maps on a cohort of 20 prostate cancer patients and compare the methods' performance in discriminating benign from cancerous tissue via Wilcoxon's signed‐rank test.
Results
In simulations, ssVERDICT outperforms the baseline methods (nonlinear least squares and supervised deep learning) in estimating all the parameters from the VERDICT prostate model in terms of Pearson's correlation coefficient, bias, and mean‐squared error. In vivo, ssVERDICT shows stronger lesion conspicuity across all parameter maps, and improves discrimination between benign and cancerous tissue over the baseline methods. Conclusion ssVERDICT significantly outperforms state‐of‐the‐art methods for VERDICT model fitting and shows, for the first time, fitting of a detailed multicompartment biophysical diffusion MRI model with machine learning without the requirement of explicit training labels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Medical Image Computing, Department of Computer Science, University College London, London, UK.
- Center for Medical Imaging, Division of Medicine, University College London, London, UK.
- Department of Targeted Intervention, Division of Surgery and Interventional Science, University College London, London, UK.
- Cardiff University Brain Research Imaging Center, School of Psychology, Cardiff University, Cardiff, UK.
- School of Computer Science and Informatics, Cardiff University, Cardiff, UK.
ORCID-Profile: Snigdha Sen, David Atkinson, Eleftheria Panagiotaki
Förderung
- Engineering and Physical Sciences Research Council
- University College London Hospitals
- Prostate Cancer UK
- University College London Hospitals NHS Foundation Trust
Zitieren
APA
Sen, S., Singh, S., Pye, H., Moore, C. M., Whitaker, H. C., Punwani, S., Atkinson, D., Panagiotaki, E., & Slator, P. J. (2024). ssVERDICT: Self‐supervised VERDICT‐MRI for enhanced prostate tumor characterization. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.30186
Vancouver
Sen S, Singh S, Pye H, Moore CM, Whitaker HC, Punwani S, et al. ssVERDICT: Self‐supervised VERDICT‐MRI for enhanced prostate tumor characterization. Magnetic Resonance in Medicine. 2024. doi:10.1002/mrm.30186
BibTeX
@article{Sen2024,
author = {Sen, Snigdha and Singh, Saurabh and Pye, Hayley and Moore, Caroline M and Whitaker, Hayley C and Punwani, Shonit and Atkinson, David and Panagiotaki, Eleftheria and Slator, Paddy J},
title = {ssVERDICT: Self‐supervised VERDICT‐MRI for enhanced prostate tumor characterization},
journal = {Magnetic Resonance in Medicine},
year = {2024},
doi = {10.1002/mrm.30186}
}
EUVIMED